In-silico Studies and Antioxidant and Neuroprotective Assessment of Microencapsulated Celecoxib against Scopolamine-induced Alzheimer’s Disease
In addition to that, histopathological examination of the hippocampus part showed remarkable improvement in brain cells. So, the findings of the results revealed that MCXB, in a dose-dependent manner, showed a neuroprotective effect against scopolamine-induced AD. This effect may be attributed to the activation of cholinergic pathways.
Authors
- Rajendra Herur Vishnumurthy
- M. Gnana Ruba Priya (ORCID: https://orcid.org/0000-0002-1557-0204)
- Prashant Tiwari (ORCID: https://orcid.org/0000-0003-4423-6819)
- Viswas Raja Solomon (ORCID: https://orcid.org/0000-0002-9863-4452)
Institutions
- MNR Medical College and Hospital (IN)
- Dayananda Sagar University (IN)
- Dr. Hari Singh Gour University (IN)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2024-08-29
- DOI
- https://doi.org/10.2174/0113816128298289240723103828
- Citations
- 3
- Primary Topic
- Cholinesterase and Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.34